item management s discussion and analysis of financial condition and results of operations this report contains forward looking statements  within the meaning of section e of the securities exchange act of  as amended  which reflect the company s expectation or belief concerning future events that involve risks and uncertainties 
the actions and performance of the company could differ materially from what is contemplated by the forward looking statements contained in this report 
factors that might cause differences from the forward looking statements include those referred to or identified in item above 
reference should be made to such factors and all forward looking statements are qualified in their entirety by the above cautionary statements 
all dollar amounts in thousands results of operations fiscal year compared to fiscal year net sales for were  as compared to  for  an increase of  or 
net sales for the specialty products segment were  for as compared to  for  an increase of or 
this increase was attributable primarily to increased volumes sold of ethylene oxide related products 
net sales for the encapsulated products segment were  for as compared to  for  an increase of  or 
this increase was due principally to greater sales to the animal nutrition  specialty industrial and domestic food markets 
the growth in sales to the food market is the result of increased volumes sold of higher margin products which can be attributed principally to new products and new applications  combined with additional sales representation 
in late  the company launched reashure tm  its encapsulated choline for ruminant animals  after having successfully completed university and field trials 
commercial sales are currently targeted to the dairy industry where reashure tm delivers nutrient supplements through the rumen providing required levels to dairy cows during certain weeks preceding and following calving  commonly referred to as the transition period of the animal 
sales of reashure tm continued to develop through growth from existing customers and with the addition of new customers primarily in the east and midwest 
gross profit as a percent of sales for was as compared to for margins for the specialty products segment were favorably affected primarily by increased volumes sold and improved production efficiencies of blended ethylene oxide products which the company now sells for non medical sterilization 
margins also improved in the encapsulated products division  a result of efficiencies realized from increased production and the mix of products sold during operating expenses for increased to  from  for  an increase of or 
the increase in operating expenses was primarily the result of increased advertising expense and travel expenses and increased payroll expense in the area of sales and marketing for the encapsulated products segment 
in particular  additional sales personnel have been added to support the animal nutrition business 
the company expended  and  in and  respectively  on company sponsored research and development programs  substantially all of which pertained to the company s encapsulated products segment for both food and animal feed applications 
the decline in these research and development expenses is a result of the company having completed the gathering of data for reashure tm from university studies  commercial field trials and veterinarians in as a result of the foregoing  earnings from operations for were  as compared to  for earnings from operations for the specialty products segment for was  as compared to  for earnings from operations for the encapsulated products segment for was as compared to a loss of for net interest income for totaled as compared to net interest expense of for long term debt was eliminated in from  in resulting in lower interest expense 
the company s effective income tax rate was for as compared with for due principally to the effects of the company s utilization of net operating loss carry forwards for state income tax purposes in the second quarter of as a result of the foregoing  net earnings were  for as compared to  for fiscal year compared to fiscal year net sales for were  as compared to  for  an increase of or 
net sales for the specialty products segment were  for as compared to  for  an increase of or 
this increase was attributable primarily to an increase in volumes sold of the company s ethylene oxide product partially offset by a decline in volumes sold of the company s methyl chloride product 
net sales for the encapsulated products segment were  for as compared to  for an increase of or 
this increase was primarily the result of increased sales in the domestic food markets partially offset by decreased sales in the international food and animal nutrition markets 
with successful university and field trials conducted in  targeted at the dairy industry and in particular the transition period of the dairy cow  the company launched reashure tm  its encapsulated choline for animal feed in the fourth quarter of gross profit as a percent of sales for was as compared to in margins for the specialty products segment were affected favorably by increased volumes sold of ethylene oxide and improved production efficiencies of blended ethylene oxide products  a result of the company s decision to blend internally rather than use third party blenders 
these margin improvements were partially offset by declines in volumes produced and sold of the company s methyl chloride product and additional amortization expense associated with the early purchase price buy out option under the agreement pertaining to the acquisition by the specialty products segment 
margins in the encapsulated products division declined two percentage points in as compared to  principally as a result of the mix of products sold into the international food market 
operating expenses for increased to  from  for  an increase of or 
the increase in operating expenses was primarily the result of increased payroll expense in the area of selling and applications research and development  increased advertising costs and increased r d consulting expenses in the encapsulated products segment 
these increases were partially offset by a decrease in consulting fees in the specialty products segment and other payroll related expenses 
during and  the company spent  and  respectively  on research and development programs substantially all of which pertained to the company s encapsulated products segment for both food and animal feed applications 
the company incurred considerable development expenses in the gathering of data for reashure tm from university and veterinarian studies as well as field trials to accelerate the marketing effort for this product 
as a result of the foregoing  earnings from operations for were  as compared to  for earnings from operations for the specialty products segment for was  as compared to  for loss from operations for the encapsulated products segment for was  a result of lower margins and increased research and development expenses as described above  as compared to income of for net interest expense for totaled as compared to for long term debt was reduced to  in from  in  a reduction of  resulting in lower interest expense 
the company s effective income tax rate increased in as compared to due principally to the effects of the company s utilization of net operating loss carry forwards for state income tax purposes in as a result of the foregoing  net earnings were  for as compared to  for liquidity and capital resources cash flows provided by operating activities were  for as compared with  for the increase in cash flows from operating activities was due primarily to increased net earnings  reduced inventory levels and increases in accounts payable  income taxes payable and other accrued expense balances  a result of timing of payments made to vendors and other service providers partially offset by an increase in accounts receivable 
capital expenditures were for capital expenditures are projected to be approximately  for in june  the board of directors authorized the repurchase of up to  shares of the company s outstanding common stock over a two year period commencing july  as of december    shares had been repurchased under the program at a total cost of  of which   shares had been issued by the company as of such date under employee benefit plans and for the exercise of stock options 
the company intends to acquire shares from time to time at prevailing market prices if and to the extent it deems it advisable to do so based among other factors on its assessment of corporate cash flow and market conditions 
during  the company paid off its remaining long term debt of  there was no long term debt outstanding at december  the company knows of no current or pending demands on or commitments for its liquid assets that will materially affect its liquidity 
management believes current cash balances and expected operating cash flow will be sufficient to fund operations in the next year 
the company currently has approval for a  line of credit from its principal bank 
there were no outstanding borrowings under this line of credit on december  impact of recent accounting standards in june  the financial accounting standards board issued statement no 
 as amended  accounting for derivative instruments and hedging activities 
it requires that an entity recognize all derivatives as either assets or liabilities in the statement of financial position and measure those instruments at fair value 
this statement  as amended  is effective for all fiscal quarters of fiscal years beginning after june  adoption of this statement is not expected to have a material effect on the company s financial position or results of operations upon adoption effective january  because the company does not currently have derivative financial instruments or derivative commodity instruments  nor does the company have any financial instruments entered into for trading or hedging purposes 
item a 
quantitative and qualitative disclosures about market risk in the normal course of operations  the company is exposed to market risks arising from adverse changes in interest rates 
market risk is defined for these purposes as the potential change in the fair value of debt instruments resulting from an adverse movement in interest rates 
as of december   the company did not have any long term borrowings 
the company s short term working capital borrowings have historically borne interest based on the prime rate 
the company believes that its exposure to market risk relating to interest rate risk is not material  as it presently does not have any outstanding debt 
the company has no derivative financial instruments or derivative commodity instruments  nor does the company have any financial instruments entered into for trading or hedging purposes 
foreign sales are generally billed in us dollars 
the company believes that its business operations are not exposed in any material respect to market risk relating to foreign currency exchange risk or commodity price risk 

